First Time Loading...

Shanghai Rongtai Health Technology Corp Ltd
SSE:603579

Watchlist Manager
Shanghai Rongtai Health Technology Corp Ltd Logo
Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
Watchlist
Price: 23.26 CNY 2.2%
Updated: May 2, 2024

Net Margin
Shanghai Rongtai Health Technology Corp Ltd

10.9%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
202.7m
/
Revenue
1.9B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CN
Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
3.1B CNY
11%
JP
Shimano Inc
TSE:7309
2.3T JPY
13%
JP
Bandai Namco Holdings Inc
TSE:7832
2T JPY
7%
US
Hasbro Inc
NASDAQ:HAS
8.4B USD
-30%
US
Mattel Inc
NASDAQ:MAT
6.2B USD
5%
US
Brunswick Corp
NYSE:BC
5.5B USD
7%
CA
BRP Inc
TSX:DOO
6.9B CAD
7%
US
Polaris Inc
NYSE:PII
4.7B USD
5%
US
Acushnet Holdings Corp
NYSE:GOLF
3.9B USD
8%
UK
Games Workshop Group PLC
LSE:GAW
3.1B GBP
28%
JP
Yamaha Corp
TSE:7951
564.5B JPY
8%
Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
Country CN
Market Cap 3.1B CNY
Net Margin
11%
Shimano Inc
TSE:7309
Country JP
Market Cap 2.3T JPY
Net Margin
13%
Bandai Namco Holdings Inc
TSE:7832
Country JP
Market Cap 2T JPY
Net Margin
7%
Hasbro Inc
NASDAQ:HAS
Country US
Market Cap 8.4B USD
Net Margin
-30%
Mattel Inc
NASDAQ:MAT
Country US
Market Cap 6.2B USD
Net Margin
5%
Brunswick Corp
NYSE:BC
Country US
Market Cap 5.5B USD
Net Margin
7%
BRP Inc
TSX:DOO
Country CA
Market Cap 6.9B CAD
Net Margin
7%
Polaris Inc
NYSE:PII
Country US
Market Cap 4.7B USD
Net Margin
5%
Acushnet Holdings Corp
NYSE:GOLF
Country US
Market Cap 3.9B USD
Net Margin
8%
Games Workshop Group PLC
LSE:GAW
Country UK
Market Cap 3.1B GBP
Net Margin
28%
Yamaha Corp
TSE:7951
Country JP
Market Cap 564.5B JPY
Net Margin
8%

Profitability Report

View the profitability report to see the full profitability analysis for Shanghai Rongtai Health Technology Corp Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
202.7m
/
Revenue
1.9B
What is the Net Margin of Shanghai Rongtai Health Technology Corp Ltd?

Based on Shanghai Rongtai Health Technology Corp Ltd's most recent financial statements, the company has Net Margin of 10.9%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.